## CPAY: Corpay, Inc. - XLK: Technology

### Executive Summary

VALUE thesis: PEG 0.90 indicates fundamental undervaluation. Quality metrics strong (ROE 29%). Consistent execution (3/4 quarters beat estimates). Caution: momentum weakening (-2.4% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($298.65)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | Oppenheimer | $380 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | Oppenheimer | up | Outperform |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 60.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- JPMORGAN CHASE & CO: 12.7% (+93.8%)
- Vanguard Group Inc: 11.7% (+0.7%)
- Blackrock Inc.: 9.0% (+0.3%)
- Orbis Allan Gray Ltd: 5.9% (+7.1%)
- Price (T.Rowe) Assoc: 5.5% (-21.3%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.90 indicates undervaluation relative to growth. Forward P/E 12.6x attractive for 17% earnings growth. Quality metrics strong (ROE 29%, margin 24%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $22.2B |
| Beta | 0.85 |
| 52W Range | $252.84 - $400.81 |
| Short Interest | 2.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.90 |
| Forward P/E | 12.6 |
| Current P/E | 14.8 |
| YoY Growth | 16.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 5.1% to 2.6% (-2.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.4pp (needs >4.0% for momentum thesis). MRS_5 (-0.2%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 3.2% shows strong absolute momentum above own 20MA. Below SMA200 (1.00x), long-term trend not supportive. OFD pattern: +SLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.65% (CS: 71) | Neutral |
| RSI_14 | 62.3 | Neutral |
| MACD Histogram | 0.03 | Bullish |
| vs SMA20 | 1.032x | Above |
| vs SMA50 | 1.087x | Above |
| vs SMA200 | 0.998x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $313.79
- **Stop Loss:** $298.65 (4.8% risk)
- **Target:** $344.07 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 79
- **Position Value:** $24,789.41
- **Portfolio %:** 24.79%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-02-04 (Est: $5.93)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $5.64 | $5.70 | +1.0% |
| 2025Q2 | $5.12 | $5.13 | +0.1% |
| 2025Q1 | $4.51 | $4.51 | -0.1% |
| 2024Q4 | $5.35 | $5.36 | +0.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*